Investing

Advanced Micro Devices (NASDAQ: AMD stock) continued the rally on Thursday after Wall Street’s most bullish analysts unleashed fresh upgrades focused on extraordinary demand for the chipmaker’s server processors.KeyBanc Capital Markets analyst John Vinh told…

Intel Corp. shares fell as much as 5% in after-hours trading on Thursday after the chipmaker issued a first-quarter outlook that missed Wall Street expectations, tempering optimism around its long-awaited turnaround.The company forecast first-quarter revenue…

Tesla shares fell sharply on Tuesday, tracking a broad market selloff that hit large technology stocks as investors fled riskier assets amid escalating trade tensions.The electric-vehicle maker’s stock was down around 3% in midday trading,…

The artificial intelligence (AI) boom has sparked major “euphoria” across industries – sending the benchmark S&P 500 index to a near 7,000 level.Still, some Wall Street experts continue to recommend caution, citing three major risks…

Wheat prices in European Russia have dropped to their lowest level since July 2024, continuing a downward trend, according to a recent report from SovEcon. As of January 14, the average price for fourth-grade food wheat…

As the tennis world turns its attention to the opening Grand Slam of the season, Australian Open 2026, WhiteBIT, Europe’s largest cryptocurrency exchange by traffic, and Elina Svitolina — Olympic bronze medalist, Jean King Cup…

Global markets may look serene, but beneath the surface, political risk is surging.Bank of England Governor Andrew Bailey is warning that geopolitical shocks, from trade escalation to threats against Fed independence, could trigger abrupt repricing…

Markets are repricing power, not growth.Netflix just went all-cash on Warner Bros. Discovery at $27.75 a share, removing stock-risk and forcing Paramount into a credibility fight it can’t win.At the same time, geopolitics is overwhelming…

Corvus Pharmaceuticals (NASDAQ: CRVS) shares more than doubled on Jan. 20 after announcing positive Phase 1 trial data for “soquelitinib” – its oral investigational drug for atopic dermatitis.Soquelitinib demonstrated strong efficacy in treatment-resistant patients and…

Apple stock (NASDAQ: AAPL) slid nearly 3% on Tuesday, even as Evercore and Citi issued constructive notes ahead of the company’s earnings report due January 29.The disconnect highlights a fundamental market tension as analyst optimism…